- Home
- ENZ vs FGEN Comparison
ENZ vs FGEN Comparison
Compare ENZ & FGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ENZ
- FGEN
- Stock Information
- Founded
- ENZ 1976
- FGEN 1993
- Country
- ENZ United States
- FGEN United States
- Employees
- ENZ N/A
- FGEN N/A
- Industry
- ENZ Medical Specialities
- FGEN Biotechnology: Pharmaceutical Preparations
- Sector
- ENZ Health Care
- FGEN Health Care
- Exchange
- ENZ Nasdaq
- FGEN Nasdaq
- Market Cap
- ENZ 34.2M
- FGEN 33.5M
- IPO Year
- ENZ N/A
- FGEN 2014
- Fundamental
- Price
- ENZ $0.37
- FGEN $0.32
- Analyst Decision
- ENZ
- FGEN Strong Buy
- Analyst Count
- ENZ 0
- FGEN 1
- Target Price
- ENZ N/A
- FGEN $10.00
- AVG Volume (30 Days)
- ENZ 136.1K
- FGEN 1.6M
- Earning Date
- ENZ 03-17-2025
- FGEN 03-17-2025
- Dividend Yield
- ENZ 27.03%
- FGEN N/A
- EPS Growth
- ENZ N/A
- FGEN N/A
- EPS
- ENZ N/A
- FGEN N/A
- Revenue
- ENZ $29,094,000.00
- FGEN $29,621,000.00
- Revenue This Year
- ENZ N/A
- FGEN $472.13
- Revenue Next Year
- ENZ N/A
- FGEN $7.13
- P/E Ratio
- ENZ N/A
- FGEN N/A
- Revenue Growth
- ENZ N/A
- FGEN N/A
- 52 Week Low
- ENZ $0.31
- FGEN $0.18
- 52 Week High
- ENZ $1.30
- FGEN $2.40
- Technical
- Relative Strength Index (RSI)
- ENZ 24.72
- FGEN 38.86
- Support Level
- ENZ $0.45
- FGEN $0.30
- Resistance Level
- ENZ $0.50
- FGEN $0.38
- Average True Range (ATR)
- ENZ 0.04
- FGEN 0.05
- MACD
- ENZ -0.00
- FGEN -0.00
- Stochastic Oscillator
- ENZ 27.24
- FGEN 16.30
About ENZ Enzo Biochem Inc. ($0.01 Par Value)
Enzo Biochem Inc is a bioscience company. The firm manufactures, develops and sell their proprietary solutions and platforms to clinical laboratories, specialty clinics and researchers and physicians internationally. The company has one reportable segment, Products, which focuses on labeling and detection technologies from DNA to whole cell analysis, including a comprehensive portfolio of thousands of high-quality products, including antibodies, genomic probes, assays, biochemicals, and proteins.
About FGEN FibroGen Inc
FibroGen Inc is a biotechnology company focused on discovering, developing, and commercializing novel therapeutics to treat serious cancer biology and anemia. The company operates in one reportable segment: the development and commercialization of novel therapeutics to treat serious unmet medical needs. The company generates the vast majority of its revenue in Europe, followed by Japan. Virtually all of FibroGen's revenue to date has been generated from its collaboration agreements. FibroGen seeks partners with research, development, and marketing capabilities and other resources that strengthen the company's ability to advance product candidates. Geographically, it operates in United States, Japan, Europe and Others.